Today News Journal
    What's Hot

    DOJ sues Norfolk Southern over toxic train derailment in Ohio

    March 31, 2023

    Social Security funding crisis will arrive in 2033, U.S. projects

    March 31, 2023

    Richard Branson’s Virgin Orbit to lay off 85 percent of staff

    March 31, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    Today News Journal
    Contact Us
    • Home
    • Trending
    • Business
    • Health
    • Technology
      • Automobile
      • Gadgets
      • Mobiles
      • Robotics
    • Lifestyle
      • Culture
    • Sports
    • Travel
    • Editorials
    • News
      • Politics
    Today News Journal
    Home » Health » FDA expected to OK additional Covid-19 booster shots for adults 50 and over this week
    Health

    FDA expected to OK additional Covid-19 booster shots for adults 50 and over this week

    James MartinBy James MartinMarch 31, 2022No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Two sources familiar with the government’s plans said the US Food and Drug Administration is planning authorize a fourth dose of the Pfizer and Moderna mRNA vaccines for adults who are age 50 and older this week.

    The US Centers for Disease Control and Prevention is expected to follow soon after with what’s known as a permissive recommendation, which means that the shots will not be officially recommended but may be given to people who want them, said a source who spoke to CNN on the condition of anonymity since they had not been given permission to discuss the details with reporters.

    Details of the plans were first reported by The New York Times.

    The decision to make fourth doses available now will bypass independent groups of scientific advisers for both the FDA and CDC, which would normally meet and publicly review the available science and then make recommendations to the agencies.

    Dr. Eric Topol, a cardiologist who is director of the Scripps Translational Research Institute in California, said the decision was expected ahead of an April 6 meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC), a group of independent experts who advise the FDA on its vaccine decisions. Boosters are on the agenda for discussion at that meeting, which will focus on future planning for boosters and variant-specific vaccines.

    Topol, who was apprised of the FDA’s plans, said it was his understanding that the change would apply to both the Pfizer/BioNTech and Moderna vaccines.

    Topol also said he was in favor of giving Americans the option of fourth doses.

    Pfizer/BioNTech seek FDA authorization for fourth Covid-19 vaccine doses for people 65 and up

    “There are solid data from Israel for age 60+ (the only group reported on to date) for enhanced protection (vs severe illness) out to 3 months compared with 3 doses. It is reasonable to extend that and provide it as an option, since the 3rd dose has pronounced benefit in age 50+,” Topol wrote in an email to CNN.

    Topol noted that the FDA’s move legitimizes what many Americans are doing anyway. Anyone who wants a fourth dose can go to a pharmacy and receive one just by saying that they need one because they are immunocompromised.

    Others felt there wasn’t yet enough science available to support the decision.

    Dr. Eric Rubin, editor in chief of The New England Journal of Medicine who sits on the FDA’s VRBPAC, said he hadn’t yet seen enough data on fourth doses to make a determination about whether they are needed for anyone beyond those who are already recommended to get them — adults who are severely immune deficient.

    “The only data that I’ve seen has been for participants followed for just a few weeks. The most important information is going to be how well a fourth dose protects highly vulnerable people against serious disease and death, and I don’t know when that will be available,” Rubin said in an email to CNN. Rubin said the FDA might have access to that data, but he had not seen it yet.

    Dr. Paul Offit, director of the vaccine education center at the Children’s Hospital of Philadelphia and a member of the FDA’s VRBPAC, also said he felt the administration was acting ahead of the science.

    “Where’s the evidence that somebody over 50 benefits from a fourth dose? Because the evidence to date appears to support the possibility for those over 65, although I haven’t, we haven’t, seen all the data,” Offit told CNN, speaking of the VRBPAC committee members. “But where’s the evidence for a 50 to 64 year old? Where’s that evidence? Because absent that evidence, then there shouldn’t be this recommendation,” he said.



    Source link

    Related posts:

    1. What are the UK's 'Living with Covid' plans?
    2. Tracking Covid-19 cases in the US
    3. Opioid Crisis Fast Facts | CNN
    4. Food packaging contains dangerous chemicals, report says
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleRevealed: migrant workers in Qatar forced to pay billions in recruitment fees | Workers’ rights
    Next Article ‘It could have been us’: WNBA players speak out on Brittney Griner detention | WNBA
    James Martin
    • Website

    Related Posts

    California bill seeks to ban red dye No. 3

    March 29, 2023

    Stricter air pollution standards would benefit some populations more than others, study says

    March 29, 2023

    Alzheimer’s first signs may appear in your eyes, study finds

    March 29, 2023

    Colorectal cancer is rising among younger adults and scientists are racing to uncover why

    March 28, 2023

    Leave A Reply Cancel Reply

    Search
    Categories
    • Automobile
    • Business
    • Coronavirus
    • Culture
    • Editorials
    • Finance
    • Gadgets
    • Health
    • Lifestyle
    • Mobiles
    • Money
    • News
    • Politics
    • Sports
    • Technology
    • Travel
    • Trending
    • World
    Latest Posts

    DOJ sues Norfolk Southern over toxic train derailment in Ohio

    March 31, 2023

    Social Security funding crisis will arrive in 2033, U.S. projects

    March 31, 2023

    Richard Branson’s Virgin Orbit to lay off 85 percent of staff

    March 31, 2023

    Yorkshire racism allegations: Vaughan cleared, three charges against Hoggard considered proven – live | Yorkshire

    March 31, 2023
    • Facebook
    • Twitter
    Don't Miss
    News

    DOJ sues Norfolk Southern over toxic train derailment in Ohio

    By James MartinMarch 31, 20230

    Comment on this storyCommentThe Justice Department filed a major civil suit Friday against Norfolk Southern…

    Social Security funding crisis will arrive in 2033, U.S. projects

    March 31, 2023

    Richard Branson’s Virgin Orbit to lay off 85 percent of staff

    March 31, 2023

    Yorkshire racism allegations: Vaughan cleared, three charges against Hoggard considered proven – live | Yorkshire

    March 31, 2023
    • Facebook
    • Twitter
    About Us

    Hello friends, I am James Martin. Welcome to my blog todaynewsjournal.com. We are a team of experienced journalists who are passionate about delivering the latest news and current events to our readers. Our editorial team is dedicated to providing the most accurate and up-to-date information possible. We aim to be your go-to source for news and current events. Here on this site, You will get up to date information regarding all important categories like business ideas, health tips,... (Read More)

    Latest News

    DOJ sues Norfolk Southern over toxic train derailment in Ohio

    March 31, 2023

    Social Security funding crisis will arrive in 2033, U.S. projects

    March 31, 2023

    Richard Branson’s Virgin Orbit to lay off 85 percent of staff

    March 31, 2023
    SIGN UP NEWSLETTER

    Join The Conversation sign up to receive emails for The Daily special tips general info.

      Facebook Twitter Instagram Pinterest
      • Home
      • Editorials
      • Get In Touch

      Copyright © 2021-2023 · Today News Journal Privacy Policy

      Type above and press Enter to search. Press Esc to cancel.

      We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
      Cookie SettingsAccept All
      Manage consent

      Privacy Overview

      This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
      Necessary
      Always Enabled
      Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
      CookieDurationDescription
      cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
      cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
      cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
      cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
      cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
      viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
      Functional
      Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
      Performance
      Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
      Analytics
      Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
      Advertisement
      Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
      Others
      Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
      SAVE & ACCEPT

      Sign In or Register

      Welcome Back!

      Login to your account below.

      Lost password?